Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors
C Li, Y Wang, Y Gong, T Zhang, J Huang, Z Tan… - Clinical …, 2021 - Springer
Enhancer of zeste homolog 2 inhibitors (EZH2i) have garnered increased attention owing to
their anticancer activity by targeting EZH2, a well-known cancer-promoting factor. However …
their anticancer activity by targeting EZH2, a well-known cancer-promoting factor. However …
Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms
A Ameri, HM Ahmed, RDC Pecho, H Arabnozari… - Cancer Cell …, 2023 - Springer
There is a growing interest to understand the role and mechanism of action of microRNAs
(miRNAs) in cancer. The miRNAs are defined as short non-coding RNAs (18-22nt) that …
(miRNAs) in cancer. The miRNAs are defined as short non-coding RNAs (18-22nt) that …
Feature selection may improve deep neural networks for the bioinformatics problems
Z Chen, M Pang, Z Zhao, S Li, R Miao, Y Zhang… - …, 2020 - academic.oup.com
Motivation Deep neural network (DNN) algorithms were utilized in predicting various
biomedical phenotypes recently, and demonstrated very good prediction performances …
biomedical phenotypes recently, and demonstrated very good prediction performances …
Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage …
X Zhou, H Chen, Y Hu, X Ma, J Li, Y Shi, M Tao… - Cell death & …, 2023 - nature.com
Long-term follow-up data indicates that 1/4 patients with acute kidney injury (AKI) will
develop to chronic kidney disease (CKD). Our previous studies have demonstrated that …
develop to chronic kidney disease (CKD). Our previous studies have demonstrated that …
Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1
DW Liu, JH Zhang, FX Liu, XT Wang, SK Pan… - … & molecular medicine, 2019 - nature.com
The number of patients with diabetic nephropathy (DN) is still on the rise worldwide, and this
requires the development of new therapeutic strategies. Recent reports have highlighted …
requires the development of new therapeutic strategies. Recent reports have highlighted …
hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223
X Zhang, P Tan, Y Zhuang, L Du - American Journal of …, 2020 - journals.physiology.org
Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular
RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as …
RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as …
New insights into the implication of epigenetic alterations in the EMT of triple negative breast cancer
Breast cancer is the most common cancer and leading cause of cancer death among
women worldwide, encompassing a wide heterogeneity of subtypes with different clinical …
women worldwide, encompassing a wide heterogeneity of subtypes with different clinical …
Fucoxanthin extracted from Laminaria Japonica inhibits metastasis and enhances the sensitivity of lung cancer to Gefitinib
JX Ming, ZC Wang, Y Huang, H Ohishi, RJ Wu… - Journal of …, 2021 - Elsevier
Ethnopharmacological relevance Laminaria japonica, a brown seaweed, has been used in
Traditional Chinese Medicine (TCM) to treat a variety of diseases including lung cancer. Aim …
Traditional Chinese Medicine (TCM) to treat a variety of diseases including lung cancer. Aim …
Proteins found in the triple-negative breast cancer secretome and their therapeutic potential
PR McHenry, JR Prosperi - International Journal of Molecular Sciences, 2023 - mdpi.com
The cancer secretome comprises factors secreted by tumors, including cytokines, growth
factors, proteins from the extracellular matrix (ECM), proteases and protease inhibitors …
factors, proteins from the extracellular matrix (ECM), proteases and protease inhibitors …
Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets
TM Milan, APE Eskenazi, LD de Oliveira, G da Silva… - Cellular …, 2023 - Elsevier
The Wnt/β-catenin signaling pathway is associated with the regulation of cancer stem cells,
and it can be driven by epigenetic modifications. Here, we aim to identify epigenetic …
and it can be driven by epigenetic modifications. Here, we aim to identify epigenetic …